FDA Approves a New Dose of INGREZZA (Valbenazine) based on Model-Informed Drug Development (MIDD)
On April 23, 2021, the FDA approved a supplemental NDA (sNDA) for a new dose (60 ...
Read moreOn April 23, 2021, the FDA approved a supplemental NDA (sNDA) for a new dose (60 ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.